Sanctuary Advisors LLC decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 104,633 shares of the company’s stock after selling 6,638 shares during the period. Sanctuary Advisors LLC’s holdings in Colgate-Palmolive were worth $9,510,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in CL. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $36,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth about $42,000. Roxbury Financial LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $43,000. Finally, Synergy Asset Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $49,000. Institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the company. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Trading Up 0.4 %
Shares of NYSE CL opened at $86.41 on Wednesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The business’s 50 day moving average price is $89.39 and its 200-day moving average price is $96.22. Colgate-Palmolive has a fifty-two week low of $83.70 and a fifty-two week high of $109.30. The company has a market cap of $70.60 billion, a price-to-earnings ratio of 24.55, a PEG ratio of 4.12 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 EPS. On average, sell-side analysts expect that Colgate-Palmolive will post 3.73 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s payout ratio is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is the NASDAQ Stock Exchange?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.